REPERFUSION INJURY
Clinical trials for REPERFUSION INJURY explained in plain language.
Never miss a new study
Get alerted when new REPERFUSION INJURY trials appear
Sign up with your email to follow new studies for REPERFUSION INJURY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to limit heart damage after major attack
Disease control Recruiting nowThis study tests a medicine called Xolatryp in adults who have had a severe heart attack (STEMI) and are getting a procedure to open blocked arteries. Participants receive either a single 6-hour infusion of Xolatryp or a placebo, and their heart health is monitored for 30 days. T…
Matched conditions: REPERFUSION INJURY
Phase: PHASE2 • Sponsor: Nyrada Pty Ltd • Aim: Disease control
Last updated Jul 02, 2026 03:00 UTC
-
Chilling the heart: could cooling arteries prevent attack aftermath?
Disease control Recruiting nowThis study tests a new way to reduce heart damage after a severe heart attack (STEMI). Doctors will cool the heart's arteries during the standard procedure to open blocked vessels. The goal is to see if this cooling prevents further injury and improves heart function. The trial i…
Matched conditions: REPERFUSION INJURY
Phase: NA • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC